Your browser doesn't support javascript.
loading
Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse.
Dimopoulos, Meletios; Weisel, Katja; Moreau, Philippe; Anderson, Larry D; White, Darrell; San-Miguel, Jesus; Sonneveld, Pieter; Engelhardt, Monika; Jenner, Matthew; Corso, Alessandro; Dürig, Jan; Pavic, Michel; Salomo, Morten; Casal, Eva; Srinivasan, Shankar; Yu, Xin; Nguyen, Tuong Vi; Biyukov, Tsvetan; Peluso, Teresa; Richardson, Paul.
Afiliação
  • Dimopoulos M; National and Kapodistrian University of Athens, Athens, Greece. mdimop@med.uoa.gr.
  • Weisel K; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Moreau P; University Hospital Hôtel-Dieu, Nantes, France.
  • Anderson LD; The University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • White D; Dalhousie University and Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada.
  • San-Miguel J; Clinica Universidad de Navarra, CIMA, IDISNA, Pamplona, Spain.
  • Sonneveld P; Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Engelhardt M; Faculty of Freiburg, Universitätsklinikum Freiburg, Freiburg, Germany.
  • Jenner M; University Hospital Southampton, Southampton, UK.
  • Corso A; Division of Hematology, Hospital Legnano, Milan, Italy.
  • Dürig J; University Medicine Essen, Essen, Germany.
  • Pavic M; Centre Hospitalier Universitaire De Sherbrooke (CHUS) - Centre de Recherche Clinique Etienne-Le Bel (CRCELB) Hôpital Fleurimont, Sherbrooke, QC, Canada.
  • Salomo M; Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Casal E; Bristol Myers Squibb, Summit, NJ, USA.
  • Srinivasan S; Bristol Myers Squibb, Summit, NJ, USA.
  • Yu X; Bristol Myers Squibb, Summit, NJ, USA.
  • Nguyen TV; Bristol Myers Squibb, Summit, NJ, USA.
  • Biyukov T; Celgene International Sàrl, Bristol Myers Squibb Company, Boudry, Switzerland.
  • Peluso T; Celgene International Sàrl, Bristol Myers Squibb Company, Boudry, Switzerland.
  • Richardson P; Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Leukemia ; 35(6): 1722-1731, 2021 06.
Article em En | MEDLINE | ID: mdl-32895455
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Terapia de Salvação / Resistencia a Medicamentos Antineoplásicos / Mieloma Múltiplo / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Terapia de Salvação / Resistencia a Medicamentos Antineoplásicos / Mieloma Múltiplo / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article